Large-scale testing (Phase 3)Study completedNCT00329745
What this trial is testing
Year 3 Extension for Efficacy Follow-up in Subjects Vaccinated in Studies Rota-028, 029 or 030 (NCT00197210)
Who this might be right for
Infections, Rotavirus
GlaxoSmithKline 8,687